Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Structural and functional insight into how the Plasmodium falciparum VAR2CSA protein mediates binding to chondroitin sulfate A in placental malaria

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Risk Factors for Being Seronegative following SARS-CoV-2 Infection in a Large Cohort of Health Care Workers in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Labour market affiliation among non-bullied colleagues at work units with reported bullying

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Risk of COVID-19 in health-care workers in Denmark: an observational cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Malaria is a major global health problem. Pregnant women are susceptible to infection regardless of previously acquired immunity. Placental malaria is caused by parasites capable of sequestering in the placenta. This is mediated by VAR2CSA, a parasite antigen that interacts with chondroitin sulfate A (CSA). One vaccine strategy is to block this interaction with VAR2CSA-specific antibodies. It is a priority to define a small VAR2CSA fragment that can be used in an adhesion blocking vaccine. In this, the obvious approach is to define regions of VAR2CSA involved in receptor binding. It has been shown that full-length recombinant VAR2CSA binds specifically to CSA with nanomolar affinity, and that the CSA-binding site lies in the N-terminal part of the protein. In this study we define the minimal binding region by truncating VAR2CSA and analyzing CSA binding using biosensor technology. We show that the core CSA-binding site lies within the DBL2X domain and parts of the flanking interdomain regions. This is in contrast to the idea that single domains do not possess the structural requirements for specific CSA binding. Small-angle x-ray scattering measurements enabled modeling of VAR2CSA and showed that the CSA-binding DBL2X domain is situated in the center of the structure. Mutating classic sulfate-binding sites in VAR2CSA, along with testing dependence of ionic interactions, suggest that the CSA binding is not solely dependent on the sulfated CSA structure. Based on these novel PfEMP1 structure-function studies, we have constructed a small VAR2CSA antigen that has the capacity to induce highly adhesion-blocking antibodies.
Original languageEnglish
JournalJournal of Biological Chemistry
Volume287
Issue number28
Pages (from-to)23332-45
Number of pages14
ISSN0021-9258
DOIs
Publication statusPublished - 2012

    Research areas

  • Animals, Antigens, Protozoan, Binding Sites, Chondroitin Sulfates, Female, Host-Parasite Interactions, Humans, Immune Sera, Immunization, Kinetics, Malaria, Falciparum, Models, Molecular, Mutation, Placenta, Plasmodium falciparum, Pregnancy, Pregnancy Complications, Parasitic, Protein Binding, Protein Structure, Tertiary, Protozoan Proteins, Rats, Rats, Wistar, Recombinant Proteins, Scattering, Small Angle, X-Ray Diffraction

ID: 36490978